Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dyadic International, Inc. - Common Stock
(NQ:
DYAI
)
1.380
+0.030 (+2.22%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dyadic International, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Dyadic International Inc. (NASDAQ: DYAI) Surges 19.2% Amid Robust Trading Volume Following Expanded Collaboration with Israeli Institutes
February 21, 2024
Via
AB Newswire
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
February 19, 2024
Via
Benzinga
Latest Buzz on The Street: Noteworthy Developments at DYAI, ELEV, ATRA, ESPR, KAVL
January 17, 2024
Via
AB Newswire
Recap: Dyadic International Q3 Earnings
November 08, 2023
Via
Benzinga
Nasdaq Stocks Are Taking Center Stage This Week! DYAI, MRVI, SPWR, VTAK, KAVL, INBS
February 19, 2024
Via
AB Newswire
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
Biopharmaceutical Advancements: Dyadic (Nasdaq: DYAI) Raises Industry Standards with Maravai LifeSciences’ (Nasdaq: MRVI) Cygnus Technologies
February 14, 2024
Via
AB Newswire
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
February 13, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
Breaking Ground in BioPharma: Spotlight Companies DYAI, INBS, SANA, IOVA, BLUE
February 12, 2024
Via
AB Newswire
Dyadic Announces Research and Development Collaboration Agreement with Global Biopharmaceutical Company
February 06, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
Top 5 Active Stock Buzzers Under $10: INBS, PLUG, KOPN, DYAI, MINM
February 05, 2024
Via
AB Newswire
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
February 01, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
“Revolutionizing Biotechnology: Dyadic International (NASDAQ: DYAI) Leads with C1 Platform for Swift and Efficient Protein Production”
January 11, 2024
Via
AB Newswire
Bull Run 2024: Biopharma Healthcare Stocks Surge, Gaining Momentum: DYAI, ABVC, FWBI, VTAK, NEXI
January 05, 2024
Via
AB Newswire
“Dyadic International Inc. (NASDAQ: DYAI): Zacks Small-Cap Research Indicates Valuation at $9.00 per Share”
January 05, 2024
Via
AB Newswire
“Dyadic International (NASDAQ: DYAI) Revolutionizing Pharma with Innovative C1 Technology for Global Protein Development”
January 02, 2024
Via
AB Newswire
Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference
January 02, 2024
From
Dyadic International, Inc.
Via
GlobeNewswire
“2024 Market Outlook: SmallCap Radar Stocks Unveiled”: DYAI, SKYX, QUBT, KNW, VTAK
December 28, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
“Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally”
December 21, 2023
Via
AB Newswire
Exposures
COVID-19
CryptoNewsBreaks – Innovators and Ideas Showcased at 12th Annual Benchmark Discovery Conference
December 19, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Standouts from 12th Annual Benchmark Discovery Conference Featured in Nasdaq Article
December 13, 2023
Via
Investor Brand Network
Dyadic Attends Investor Events in December
November 30, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 29, 2023
Via
Benzinga
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
November 29, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
November 20, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Present at Industry Events in November
October 30, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic to Report Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
October 25, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
Dyadic Appoints Doug Pace to Its Executive Leadership Team
October 09, 2023
From
Dyadic International, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 06, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.